Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose-Finding Study”

1,793 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,793 results

Testing effectiveness (Phase 2)Study completedNCT01592500
What this trial is testing

Safety and Efficacy Phase 2 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Who this might be right for
Pediatric Growth Hormone Deficiency
OPKO Health, Inc. 56
Testing effectiveness (Phase 2)Ended earlyNCT04365400
What this trial is testing

Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes

Who this might be right for
HypertriglyceridemiaType 2 Diabetes
Afimmune 233
Testing effectiveness (Phase 2)Study completedNCT00498836
What this trial is testing

Multicentre, Dose Finding, Ph II,CP-4055 in Comb. With Sorafenib - Patients With Metastatic Malignant Melanoma

Who this might be right for
Malignant Melanoma
Clavis Pharma 18
Testing effectiveness (Phase 2)Study completedNCT03664635
What this trial is testing

MB-CART20.1 Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaB-cell Lymphoma Refractory+1 more
Miltenyi Biomedicine GmbH 10
Testing effectiveness (Phase 2)Ended earlyNCT03301597
What this trial is testing

NLA101 in Adults Receiving High Dose Chemotherapy for AML

Who this might be right for
Leukemia, Myeloid, Acute
Nohla Therapeutics, Inc. 146
Early research (Phase 1)Study completedNCT02493751
What this trial is testing

Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

Who this might be right for
Renal Cell Cancer
Pfizer 55
Testing effectiveness (Phase 2)Study completedNCT01014975
What this trial is testing

A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

Who this might be right for
Acute Ischemic Stroke
Grifols Therapeutics LLC 40
Early research (Phase 1)Study completedNCT02215096
What this trial is testing

Dose-finding Study of GSK2636771 When Administered in Combination With Enzalutamide in Male Subjects With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Neoplasms
GlaxoSmithKline 37
Testing effectiveness (Phase 2)Study completedNCT02616562
What this trial is testing

Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in Children
Novo Nordisk A/S 76
Testing effectiveness (Phase 2)Study completedNCT00252746
What this trial is testing

ZD6474 Phase IIa Dose Finding Multicentre Study

Who this might be right for
Non Small Cell Lung Carcinoma
Genzyme, a Sanofi Company 53
Not applicableStudy completedNCT05035888
What this trial is testing

Prophylactic Norepinephrine and Phenylephrine Boluses for Postspinal Anesthesia Hypotension

Who this might be right for
Adverse Effect
General Hospital of Ningxia Medical University 80
Early research (Phase 1)Study completedNCT01433445
What this trial is testing

Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis

Who this might be right for
Idiopathic MyelofibrosisPost Essential Thrombocythemia MyelofibrosisPost Polycythemia-Vera Myelofibrosis
Novartis Pharmaceuticals 61
Testing effectiveness (Phase 2)Looking for participantsNCT07415954
What this trial is testing

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT04538742
What this trial is testing

A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 245
Early research (Phase 1)Study completedNCT05614544
What this trial is testing

Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

Who this might be right for
General Anesthesia
Haisco-USA Pharmaceuticals, Inc. 42
Very early researchWithdrawnNCT05252598
What this trial is testing

Mood and Cognitive Effects of Psilocybin in Healthy Participants

Who this might be right for
Mood DisturbanceMood ChangeSleep Disturbance+7 more
Optimi Health Corporation
Early research (Phase 1)Study completedNCT05351671
What this trial is testing

A Clinical Study to Determine the Safety, Tolerability and Effect of RLS-0071 Doses When Given to Healthy Adults After Inhaling LPS

Who this might be right for
Healthy
ReAlta Life Sciences, Inc. 30
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03878446
What this trial is testing

A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

Who this might be right for
Short Stature Children Born Small for Gestational Age (SGA)
Novo Nordisk A/S 62
Testing effectiveness (Phase 2)Study completedNCT01490294
What this trial is testing

Myocardial Perfusion MRI

Who this might be right for
Myocardial Perfusion ImagingMagnetic Resonance Imaging
Bayer 232
Next Page